{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:46:03Z","timestamp":1793295963925,"version":"4.5.0"},"reference-count":27,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thailand Science Research and Innovation Fundamental Fund Fiscal Year 2024","award":["N42A671041"],"award-info":[{"award-number":["N42A671041"]}],"id":[{"id":"https:\/\/ror.org\/000025p04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Thailand Science Research and Innovation Fundamental Fund Fiscal Year 2024","award":["F 4\/2566"],"award-info":[{"award-number":["F 4\/2566"]}],"id":[{"id":"https:\/\/ror.org\/000025p04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Research Council of Thailand (NRCT)","award":["N42A671041"],"award-info":[{"award-number":["N42A671041"]}],"id":[{"id":"https:\/\/ror.org\/018wfhg78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Research Council of Thailand (NRCT)","award":["F 4\/2566"],"award-info":[{"award-number":["F 4\/2566"]}],"id":[{"id":"https:\/\/ror.org\/018wfhg78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Fund of Chulabhorn International College of Medicine","award":["N42A671041"],"award-info":[{"award-number":["N42A671041"]}]},{"name":"Research Fund of Chulabhorn International College of Medicine","award":["F 4\/2566"],"award-info":[{"award-number":["F 4\/2566"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biosensors"],"abstract":"<jats:p>Chronic kidney disease (CKD) continues to pose a critical global health challenge, making ongoing monitoring vital for effective management and preventing its progression to end-stage renal disease. The urinary albumin-to-creatinine ratio (uACR) stands out as a reliable biomarker. MyACR was developed and validated as a novel point-of-care (POC) device for identifying and monitoring the progress of CKD. MyACR device operates using a colorimetric-based spectroscopy to quantify albumin and creatinine levels at 625 nm and 515 nm, respectively. Calculated uACR values were compared with results from the reference turbidimetry method using a dataset of 103 random urine samples from patients at high risk of advanced CKD. The device showed excellent performance in detecting severe nephropathy, with sensitivity, specificity, and accuracy of 100%, 100%, and 100%, respectively. The PPV (positive predictive value) was 100%, indicating perfect identification of patients with severe nephropathy (uACR &gt; 300 mg\/g creatinine). The NPV (negative predictive value) was 100%, suggesting a strong ability to rule out severe nephropathy, though a small risk of false negatives remained. Bland\u2013Altman analysis confirmed a high level of agreement, with 96.11% (for all data) and 95.87% (for uACR &gt; 300 mg\/g creatinine) of MyACR measurements falling within the 95% confidence interval (\u221227 to +19). Correlation analysis revealed a significant alignment between MyACR and the reference method (r2 0.9720 to 0.9836). The ROC analysis suggested that combining uACR with the estimated glomerular filtration rate (eGFR) demonstrated strong predictive performance, yielding an area under the curve (AUC) of 0.933 (95% CI: 0.86\u20131.0). In conclusion, the MyACR device is a robust, affordable, and user-friendly tool for detecting nephropathy, showing performance comparable to the reference method. Its portability and cost-effectiveness make it particularly suitable for use in low-resource environments. Additionally, integrating uACR with eGFR enhances prognostic capabilities, offering a comprehensive approach to assessing kidney function and predicting CKD progression.<\/jats:p>","DOI":"10.3390\/bios15030145","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T10:52:47Z","timestamp":1740394367000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Urinary Albumin-to-Creatinine Ratio (uACR) Point-of-Care (POC) Device with Seamless Data Transmission for Monitoring the Progression of Chronic Kidney Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-1722","authenticated-orcid":false,"given":"Artitaya","family":"Thiengsusuk","sequence":"first","affiliation":[{"name":"Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napaporn","family":"Youngvises","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7871-0870","authenticated-orcid":false,"given":"Runtikan","family":"Pochairach","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab Osman","family":"Taha","sequence":"additional","affiliation":[{"name":"Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kridsada","family":"Sirisabhabhorn","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Laboratory, Thammasat University Hospital, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadda","family":"Muhamad","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Health Informatics, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchai","family":"Meesiri","sequence":"additional","affiliation":[{"name":"Bangkok High Lab Co., Ltd., Bang Khen District, Bangkok 10220, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Chaijaroenkul","sequence":"additional","affiliation":[{"name":"Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesara","family":"Na-Bangchang","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani 12120, Thailand"},{"name":"Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand"},{"name":"Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand"},{"name":"Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: An international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e000380","DOI":"10.1136\/bmjgh-2017-000380","article-title":"Chronic kidney disease and the global NCDs agenda","volume":"2","author":"Neuen","year":"2017","journal-title":"BMJ Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.crvasa.2013.07.006","article-title":"Hypertension and chronic kidney diseases","volume":"55","author":"Monhart","year":"2013","journal-title":"Cor Vasa"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shaw, K.M., and Cummings, M.H. (2005). Diabetes: Chronic Complications, Wiley Online Library.","DOI":"10.1002\/0470865814"},{"key":"ref_5","unstructured":"Vaidya, S.R., and Aeddula, N.R. (2024, May 20). Chronic Kidney Disease, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535404\/."},{"key":"ref_6","first-page":"e40031","article-title":"Risk Factors of Microalbuminuria and Macroalbuminuria in Type 2 Diabetic Patients in North of Iran\u2014Rasht","volume":"9","author":"Ansar","year":"2017","journal-title":"Nephro-Urol. Mon."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: Global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clinbiochem.2022.06.014","article-title":"Quantification of urinary albumin and -creatinine: A comparison study of two analytical methods and their impact on albumin to creatinine ratio","volume":"108","author":"Jensen","year":"2022","journal-title":"Clin. Biochem."},{"key":"ref_9","first-page":"97","article-title":"Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease","volume":"32","author":"Martin","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e22168","DOI":"10.1002\/jcla.22168","article-title":"Evaluation and comparison of Abbott Jaffe and enzymatic creatinine methods: Could the old method meet the new requirements?","volume":"32","author":"Ergon","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ansa.202000074","article-title":"Trend in creatinine determining methods: Conventional methods to molecular-based methods","volume":"2","author":"Narimani","year":"2021","journal-title":"Anal. Sci. Adv."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Muhamad, N., Youngvises, N., Plengsuriyakarn, T., Meesiri, W., Chaijaroenkul, W., and Na-Bangchang, K. (2024). MyACR: A Point-of-Care Medical Device for Determination of Albumin-Creatinine Ratio (uACR) in Random Urine Samples as a Marker of Nephropathy. Diagnostics, 14.","DOI":"10.20944\/preprints202404.1870.v1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2116\/bunsekikagaku.54.783","article-title":"Colorimetric and Visual Methods for Urinary Protein Determination with Tetrabromophenol Blue","volume":"54","author":"Hashimoto","year":"2005","journal-title":"Bunseki Kagaku"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12291-013-0299-y","article-title":"Creatinine estimation and interference","volume":"28","author":"Syal","year":"2013","journal-title":"Indian J. Clin. Biochem. IJCB"},{"key":"ref_15","first-page":"S219","article-title":"11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes\u20142024","volume":"47","author":"Committee","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","article-title":"Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation","volume":"33","author":"Keane","year":"1999","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.talanta.2012.02.027","article-title":"Simultaneous injection effective mixing flow analysis of urinary albumin using dye-binding reaction","volume":"96","author":"Ratanawimarnwong","year":"2012","journal-title":"Talanta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.saa.2014.11.080","article-title":"Detection of urinary creatinine using gold nanoparticles after solid phase extraction","volume":"138","author":"Sittiwong","year":"2015","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: Overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J. Anesthesiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"Chen","year":"2019","journal-title":"Jama"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1681\/ASN.2008070730","article-title":"Combining GFR and albuminuria to classify CKD improves prediction of ESRD","volume":"20","author":"Hallan","year":"2009","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF00573481","article-title":"Prevalence of Hypertension and Microalbuminuria in Adult Type 1 (Insulin-Dependent) Diabetic Patients Without Renal Failure in Italy\u2014Validation of Screening Techniques to Detect Microalbuminuria","volume":"29","author":"Mangili","year":"1992","journal-title":"Acta Diabetol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kosack, C.M., Kieviet, W., Bayrak, K., Milovic, A., and Page, A.L. (2015). Evaluation of the Nova StatSensor\u00ae Xpress(TM) Creatinine point-of-care handheld analyzer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122433"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/00045632231219380","article-title":"Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing","volume":"61","author":"Radley","year":"1992","journal-title":"Ann. Clin. Biochem."},{"key":"ref_27","first-page":"1","article-title":"Effectiveness of URiSCAN 2 ACR strip test for albuminuria detection in screening of kidney disease","volume":"32","author":"Kateyam","year":"2020","journal-title":"Arch. Allied Health Sci."}],"container-title":["Biosensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6374\/15\/3\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:41:40Z","timestamp":1760028100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6374\/15\/3\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["bios15030145"],"URL":"https:\/\/doi.org\/10.3390\/bios15030145","relation":{},"ISSN":["2079-6374"],"issn-type":[{"value":"2079-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}